References
- Edmondson H A, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976; 294: 470–2
- Rooks J B, Ory H W, Ishak K G, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. J Am Med Assoc 1979; 242: 644–8
- Flejou J F, Pignon J P, Le M G, Belgiti J, Barge J, Bismut H. Liver cell adenoma, focal nodular hyperplasia and contraceptive use: a French case-control study in young women. Hepatology 1994; 20(Suppl 280a), abstr 736
- Dourakis S, Tolis G. Sex hormone preparations and the liver. Eur J Contracept Reprod Health Care 1998; 3: 7–16
- Baum J K, Holtz F, Bookstein J J, Klein E W. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926–9
- World Health Organization. Oral Contraceptives and Neoplasia. WHO Technical Report Series 817, WHO, Geneva 1992; 22–3
- Nagomey D M. Benign liver tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995; 19: 13–18
- Weimann A, Ringe B, Klempnauer J, et al. Benign liver tumors: differential diagnosis and indication for surgery. World J Surg 1997; 21: 983–91